Search Results 2181-2190 of 17952 for Core activity limitation

  1. ARCADIA-CSI, (Cognition and Silent Infarcts) - Mayo Clinic

    Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials · Institutional Review Board · Postdoctoral Fellowships · Training Grant ...

  2. Cerebrovascular Diseases Prospective Registry - Mayo Clinic

    Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials · Institutional Review Board · Postdoctoral Fellowships · Training Grant ...

  3. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...

  4. An Expanded Access Program Of Cretostimogene Grenadenorepvec For Treatment Of NMIBC For Patients Unresponsive To BCG - Mayo Clinic

    More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...

  5. Childhood ADPKD Database Study - Clinical Trials

    More information. Publications. Publications are currently not available. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities ...

  6. Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation - Mayo Clinic

    Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials · Institutional Review Board · Postdoctoral Fellowships · Training Grant ...

  7. Can Satisfaction with Conscious Sedation Validly Be Measured Immediately After Cataract Surgery? - Mayo Clinic

    Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials · Institutional Review Board · Postdoctoral Fellowships · Training Grant ...

  8. Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

    Phase I will follow a modified toxicity probability interval (mTPI) design, and a sentinel group will be evaluated first for dose-limiting toxicity and further ...

  9. Parkinson's Disease iPS Cell Line Research Consortium - Mayo Clinic

    More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...

  10. Diethylcarbamazine (oral route) - Mayo Clinic

    Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ... They do not track your activity online. Website Analytics. These ...